Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock ...

MaRS is proud to announce the speakers and partners coming together for its annual health innovation summit, MaRS Impact ...

Updated biographies for board candidates at the upcoming Annual General Meeting ...

A Houston-area company has just inked a massive, $1 billion deal to become the next big weight-loss medication maker. Lexicon ...

But there’s another reason for avoiding U.S. stocks that, while not an ethical consideration, gets to the heart of the ...

Volkert Reig Schmidt, manager of Lone Star, a North American fund that bought a controlling stake in Novo Banco, sold his ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

Novo Nordisk Foundation, ultimate parent of weight loss drugs Ozempic and Wegovy, awards a grant to University of Copenhagen ...

European equities, via the SPEU ETF, outshine U.S. equities this year with better value, higher yields, and diversified ...

Innergex Renewable Energy Inc. has announced that its Hale Kuawehi solar and battery storage project has achieved commercial operation. Hydro Tasmania has marked a major milestone on upgrades to the ...